• Applied Workflows with Resiniferatoxin (RTX) in TRPV1 Pain R

  2026-08-04

  Resiniferatoxin (RTX) is redefining pain research through targeted chemical inactivation of TRPV1-positive sensory neurons, offering unmatched potency and selectivity. This article delivers actionable, troubleshooting-rich protocols and translates new immunomodulatory insights for researchers using RTX as an analgesic agent for neuropathic and osteoarthritis pain.

• Br-DAPI: Illuminating DNA Damage and Repair in Live Cell Mod

  2026-08-04

  Explore how Br-DAPI, an advanced DAPI fluorescent dye, revolutionizes live cell DNA quantification and imaging. This article uniquely bridges DNA damage research, ER stress mechanisms, and high-sensitivity fluorescence analysis for robust biological insights.

• GRA12 Identified as a Conserved Virulence Factor in Toxoplas

  2026-08-03

  A recent in vivo CRISPR screen has revealed GRA12, a dense granule protein, as a critical and conserved virulence factor across multiple Toxoplasma gondii strains and mouse subspecies. This finding advances understanding of how T. gondii achieves broad host range and immune evasion, with implications for host-pathogen interaction research and potential therapeutic development.

• Tunable Human Intestinal Organoids: Balancing Renewal and Di

  2026-08-03

  This study presents a robust, tunable human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation by modulating key signaling pathways with small molecules. The approach enables greater cellular diversity and proliferative capacity under a single condition, overcoming previous limitations and supporting high-throughput organoid research.

• Applied Workflows with Toremifene Citrate: Oral SERM Innovat

  2026-08-02

  Toremifene Citrate stands out as an oral selective estrogen receptor modulator, enabling precise and reproducible modulation of ERα/ERβ in breast cancer research. This guide delivers advanced experimental workflows, troubleshooting strategies, and protocol parameters to maximize reliability and translational impact in estrogen receptor signaling studies.

• Cinoxacin: Mechanism, Spectrum, and Clinical Utility in UTI

  2026-08-01

  This article examines the mechanistic, pharmacokinetic, and therapeutic profile of cinoxacin as detailed in the reference study, highlighting its role as a quinolone antibiotic for Gram-negative urinary tract infections. The findings underscore cinoxacin's rapid urinary concentration, distinct spectrum, and favorable comparative efficacy, supporting its continued use in both clinical and laboratory settings.

• Quizartinib (AC220): Precision FLT3 Inhibition in AML Resear

  2026-07-31

  Quizartinib (AC220) delivers unmatched selectivity and nanomolar potency for FLT3 inhibition, empowering acute myeloid leukemia (AML) research with highly reproducible in vitro and in vivo workflows. Learn how advanced protocol design, troubleshooting strategies, and cross-study insights maximize its translational impact.

• iPSC-Based Disease Modeling for Cystic Fibrosis Drug Testing

  2026-07-31

  The referenced study introduces a multimodal induced pluripotent stem cell (iPSC) platform for modeling cystic fibrosis (CF), enabling functional evaluation of CFTR variants and drug responses in patient-derived airway epithelial cells. This approach enhances preclinical assessment of therapies, especially for rare and unresponsive CFTR mutations.

• 2-D08 (2’,3’,4’-trihydroxyflavone): Precision SUMOylation In

  2026-07-30

  2-D08 (2’,3’,4’-trihydroxyflavone) offers researchers a selective, potent approach to dissecting SUMO-dependent pathways in cancer and mitochondrial biology. Its unique mechanism enables unraveling posttranslational regulation with minimal off-target effects, driving next-generation experimental designs.

• Synergistic Colistin–Gamithromycin Therapy in Neutropenic Pn

  2026-07-30

  This study demonstrates that combining colistin with gamithromycin significantly enhances antimicrobial activity against multidrug-resistant Pasteurella multocida in a neutropenic murine lung infection model. The findings provide a pharmacokinetic and pharmacodynamic rationale for dual therapy, offering new directions for overcoming resistance in respiratory disease research.

• ATP Solution: Powering mRNA-LNP & Kinase Workflows with Prec

  2026-07-29

  APExBIO's ATP Solution (100 mM) stands at the heart of advanced molecular biology, enabling precise kinase reactions and robust in vitro transcription for mRNA-LNP therapeutics. This article navigates optimized protocols, troubleshooting, and translational insights, connecting bench research to breakthroughs in targeted bladder cancer therapy.

• NADH in Mitochondrial Electron Transport Chain Research

  2026-07-29

  NADH, as a reduced nicotinamide adenine dinucleotide, is pivotal for both basic and translational research targeting cellular energy metabolism. This article details nuanced experimental workflows and troubleshooting strategies that maximize NADH's utility in mitochondrial assays, disease modeling, and next-generation photocatalytic cancer therapy.

• Septin4 Drives Hypoxic Cardiomyocyte Injury via HIF-1α Degra

  2026-07-28

  This study reveals that Septin4 directly worsens hypoxia-induced injury in cardiomyocytes by promoting the von Hippel-Lindau (VHL)-mediated ubiquitination and degradation of HIF-1α. The findings deepen our mechanistic understanding of myocardial ischemia and underscore the therapeutic potential of targeting the HIF-1α degradation pathway in cardiovascular hypoxic injury.

• Applied Workflows for 5-Aminolevulinic acid HCl in Heme Bios

  2026-07-28

  5-Aminolevulinic acid HCl from APExBIO empowers research at the intersection of microbial immunity and cancer therapeutics by enabling precision in heme biosynthesis modulation. This guide translates cutting-edge findings into actionable lab protocols, troubleshooting advice, and strategic insights for maximizing assay reproducibility.

• ECL Chemiluminescent Substrate Detection Kit: Sensitivity &

  2026-07-27

  The ECL Chemiluminescent Substrate Detection Kit (Enhanced) enables highly sensitive, low-picogram protein detection in western blotting. This advanced kit from APExBIO provides stable signal duration, compatibility with diverse imaging systems, and straightforward workflow integration without protocol re-optimization.

451 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page